When the pandemic began, the global medical industry rapidly tried to grapple with the shortages alongside the mitigating of business risks. One of the many outcomes is the accelerated move towards a digital ecosystem. As a result, the future of clinical trials is evolving and aiding for cheaper and faster go-to-market by combining lab experiments, in vivo trials, and computational modelling called in silico trials.
Our speakers, Kristian Debus from Thornton Tomasetti, Virginia Chan (MBA, MSc.) from Siemens, Julianna Yeung from Fresenius Medical Care, will share case studies of how the Digital Twins accelerated complex product development to regulatory approval, while seamlessly integrating into the manufacturing process.